Related references
Note: Only part of the references are listed.Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial
Charles A Thornton et al.
LANCET NEUROLOGY (2023)
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1
Siham Ait Benichou et al.
GENE THERAPY (2022)
Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1
Siham Ait Benichou et al.
HUMAN GENE THERAPY (2022)
Changes of Gene Expression Patterns of Muscle Pathophysiology-Related Transcription Factors During Denervated Muscle Atrophy
Xiaoming Yang et al.
FRONTIERS IN PHYSIOLOGY (2022)
Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
Lubov Timchenko
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1
Lubov Timchenko
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Switching of Sox9 expression during musculoskeletal system development
Ryotaro Nagakura et al.
SCIENTIFIC REPORTS (2020)
A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1)
Joseph Horrigan et al.
PEDIATRIC NEUROLOGY (2020)
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
Renee H. L. Raaijmakers et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice
Mirella Lo Scrudato et al.
MOLECULAR THERAPY (2019)
Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice
Mei Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
Arturo Lopez Castel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Brain Structural Features of Myotonic Dystrophy Type 1 and their Relationship with CTG Repeats
Ellen van der Plas et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2019)
Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1
Christina Wei et al.
FASEB JOURNAL (2018)
Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
Sumitava Dastidar et al.
NUCLEIC ACIDS RESEARCH (2018)
Small Molecules which improve Pathogenesis of Myotonic Dystrophy Type 1
Marta Lopez-Morato et al.
FRONTIERS IN NEUROLOGY (2018)
Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9
Yanlin Wang et al.
MOLECULAR THERAPY (2018)
RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner
Kyle Lewis et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
CRISPR/Cas9-Induced (CTG.GAG)n, Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing
Ellen L. van Agtmaal et al.
MOLECULAR THERAPY (2017)
TEAD transcription factors are required for normal primary myoblast differentiation in vitro and muscle regeneration in vivo
Shilpy Joshi et al.
PLOS GENETICS (2017)
Workshop Report: consensus on biomarkers of cerebral involvement in myotonic dystrophy, 2-3 December 2014, Milan, Italy
G. Bosco et al.
NEUROMUSCULAR DISORDERS (2015)
Thrombospondin 1 Mediates High-Fat Diet-Induced Muscle Fibrosis and Insulin Resistance in Male Mice
Mayumi Inoue et al.
ENDOCRINOLOGY (2013)
TWEAK and TRAF6 regulate skeletal muscle atrophy
Ashok Kumar et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2012)
Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1
Marie Douniol et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2012)
GSK3β mediates muscle pathology in myotonic dystrophy
Karlie Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Targeting nuclear RNA for in vivo correction of myotonic dystrophy
Thurman M. Wheeler et al.
NATURE (2012)
Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 Locus
Aline Huguet et al.
PLOS GENETICS (2012)
Open-Label Trial of Recombinant Human Insulin-like Growth Factor 1/Recombinant Human Insulin-like Growth Factor Binding Protein 3 in Myotonic Dystrophy Type 1
Chad R. Heatwole et al.
ARCHIVES OF NEUROLOGY (2011)
The Thrombospondins
Josephine C. Adams et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Basement membrane components are key players in specialized extracellular matrices
Jenny Kruegel et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Myotonic Dystrophies 1 and 2: Complex Diseases with Complex Mechanisms
Benedikt Schoser et al.
CURRENT GENOMICS (2010)
Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells
Claudia Huichalaf et al.
FASEB JOURNAL (2010)
Oral Administration of a GSK3 Inhibitor Increases Brain Insulin-like Growth Factor I Levels
Marta Bolos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cognition and adaptive skills in myotonic dystrophy type 1: a study of 55 individuals with congenital and childhood forms
Anne-Berit Ekstrom et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2009)
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
Susan A. M. Mulders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1
Elizabeth Salisbury et al.
EXPERIMENTAL CELL RESEARCH (2008)
DtiStudio: Resource program for diffusion tensor computation and fiber bundle tracking
HY Jiang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2006)
Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle
XX Wang et al.
GENES & DEVELOPMENT (2005)
Cellular and molecular regulation of muscle regeneration
SBP Charge et al.
PHYSIOLOGICAL REVIEWS (2004)
Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy
A Mankodi et al.
MOLECULAR CELL (2002)
Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
N Charlet-B et al.
MOLECULAR CELL (2002)
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat
A Mankodi et al.
SCIENCE (2000)
Share Paper
